6-((2',4'-Dimethoxy-[1,1'-biphenyl]-4-yl)amino)-3-hydroxy-1-methylpyrimidine-2,4(1H,3H)-dione

ID: ALA4540166

PubChem CID: 129905847

Max Phase: Preclinical

Molecular Formula: C19H19N3O5

Molecular Weight: 369.38

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2ccc(Nc3cc(=O)n(O)c(=O)n3C)cc2)c(OC)c1

Standard InChI:  InChI=1S/C19H19N3O5/c1-21-17(11-18(23)22(25)19(21)24)20-13-6-4-12(5-7-13)15-9-8-14(26-2)10-16(15)27-3/h4-11,20,25H,1-3H3

Standard InChI Key:  RYEDJJCQUAOJMS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   11.4292   -7.7401    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1379   -8.1624    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1266   -8.9873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8353   -9.4096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8240  -10.2345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5554   -9.0069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2641   -9.4292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9842   -9.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6929   -9.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4130   -9.0462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4243   -8.2213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1444   -7.8187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8531   -8.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8418   -9.0659    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5505   -9.4881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5732   -7.8383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5846   -7.0134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3046   -6.6107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.3160   -5.7858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8758   -6.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1557   -6.9937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7156   -7.7990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9955   -8.2017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5667   -8.1820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8580   -7.7597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8693   -6.9348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4065   -9.3899    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 17 20  1  0
 20 21  2  0
 12 21  1  0
 11 22  1  0
 22 23  2  0
  8 23  1  0
  6 24  2  0
 24 25  1  0
  2 25  1  0
 25 26  2  0
  3 27  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4540166

    ---

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.38Molecular Weight (Monoisotopic): 369.1325AlogP: 2.21#Rotatable Bonds: 5
Polar Surface Area: 94.72Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 5.50CX Basic pKa: CX LogP: 2.27CX LogD: 0.48
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -0.48

References

1. Tang J, Liu F, Nagy E, Miller L, Kirby KA, Wilson DJ, Wu B, Sarafianos SG, Parniak MA, Wang Z..  (2016)  3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.,  59  (6): [PMID:26927866] [10.1021/acs.jmedchem.5b01879]

Source